Missions of the Retrieval Team - The Girl with the Silvery Smile

[davedove]

Scene 14


Media Room, Great Hall of X Marks the Scot


Mike broke into the conversation. “Wait a minute, you’re telling me that we have a socialite, spreading mind altering drugs and technology designed by Ivana Rulital and her company, in cahoots with Grant and his people from SOKS.”

“I don’t know if they’re all working together,” I answered, “But there is certainly a connection.”

“And what might that connection be?”

Ms. Starling answered, “We have found that Ritchgarl Industries, a small corporation owned entirely by Emma Ritchgarl, is in business to produce a jewelry line and beauty products. We have found that Emma made a deal with a Mr. Evan Moore Naste to produce and market her products. Mr. Naste is the Vice President of Operations for Globo-Fashion, Inc. However, other than the photo you’ve seen and the rubber chicken sporrans, we haven’t been able to find any other involvement from Grant or his people.”

“Well what are we going to do about it?”

Ms. Starling continued, “There are other benefits scheduled. I propose we go to the next one, which is scheduled for Denver in a few days. David tells me that there is an antidote for the hynotin. We will have to get access to the perfume supply and use the antidote to neutralize the hypnotin in the perfume. This will have no affect on the perfume itself; we’ve already tested that. Once we have done that, we should attempt to apprehend and question Miss Ritchgarl. Just in case, we keep an eye out for Grant and his syndicate.”

“What about the devices and the drugs that are already out there? People are going to be affected for some time yet.”

“True,” I answered, “But there is only a limited supply of the perfume and the devices only work in conjunction with the drug, so its affects will be short term. There are just too many to attempt to track them all down. The perfume isn’t scheduled for general release until next month. I propose a subsequent mission to break into the production facilities to neutralize the drugs there. We will also have to access the company files to remove the drug from the formula. Unfortunately, that still leaves the devices. But again, they are useless without the drug, so we can delay action on that until we take care of these other things first.”

“Well,” said Mike, “It sounds like you have a plan of action. I’ll leave it to you and your team to handle this. As always, if there is anything you need, just let us know.”